1. A novel, noninvasive, mRNA gene expression colon cancer screening methodology
- Author
-
D. H. Moore, Heidi Nelson, L. Wieczorek, K. V. Ballman, O. Petrauskene, Lisa A. Boardman, Y. S. Chiu, and Stephen N. Thibodeau
- Subjects
Cancer Research ,business.industry ,Colorectal cancer ,RNA ,medicine.disease ,Colon cancer screening ,Molecular biology ,Reverse transcriptase ,law.invention ,Oligonucleotide primers ,Oncology ,Mrna gene expression ,law ,Medicine ,business ,Gene ,Polymerase chain reaction - Abstract
3631 Background: An mRNA gene expression methodology testing noninvasive rectal swab samples for a panel of 16 genes, representing 4 metabolic pathways, has shown promise for detecting colon and rectal cancers in pilot studies. To test the screening potential of this methodology, we conducted a case-controlled, single-center study using samples collected from patients with a negative screening colonoscopy (Controls; n = 71) and from patients with colorectal cancer (CRC; n = 38). Methods: Controls were defined as polyp- and cancer-free patients with no family history of CRC. Rectal swabs were collected, coded, preserved in RNAProtect O solution (Qiagen), and RNA was isolated using RNeasy mini kit (Qiagen). Real time RT-PCR using reverse transcriptase (Invitrogen) and random primers and Oligo (dT) was performed on samples pretreated with RNAase-free DNase. PCR amplification with specific oligonucleotide primers was performed using Applied Biosystems 7500 Fast Real-Time PCR Systems for 16 different markers i...
- Published
- 2010
- Full Text
- View/download PDF